miDiagnostics raised €30M in a Series D funding round led by Thermo Fisher Scientific Inc. to accelerate the development of a sterility test for the BioPharma Industry.
Amount Raised
€30 Million
Round Type
Series D
HeverleeManufacturingInformation TechnologyBiotechnologyHealth CareInvestors
Description
miDiagnostics, a Leuven-based qPCR technology company, raised €30M in Series D funding to develop tests for the BioPharma Industry. The funding round was led by Thermo Fisher Scientific Inc. with participation from other investors.
Quick answer
miDiagnostics raised €30 Million in a Series D round, dated December 4, 2024. Investors: Acychlo, Vmf Invest, Pamica and Thermo Fisher Scientific Inc. miDiagnostics is based in Heverlee, Vlaanderen, Belgium.
- How much did miDiagnostics raise?
- miDiagnostics raised €30 Million in a Series D round on December 4, 2024.
- Who invested in miDiagnostics?
- Acychlo, Vmf Invest, Pamica and Thermo Fisher Scientific Inc. are named as investors in this round.
- What does miDiagnostics do?
- miDiagnostics is using silicon chip technology which will bring miniaturized, rapid, easy-to-use, lab-quality tests with built-in connectivity direct to the patient and clinician.
- Where is miDiagnostics based and how big is it?
- miDiagnostics is based in Heverlee, Vlaanderen, Belgium.
- Who are the decision-makers at miDiagnostics?
- Fundz holds 1 contact at miDiagnostics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Manufacturing and Biotechnology around the same time
Companies in the same sectors as miDiagnostics that raised within 45 days of this round, from Fundz verified event records.
- Convergence Medical raised $5M (Series A) on January 16, 2025.
- Cornerstone Robotics raised $70M (Series C) on January 13, 2025.
- NewcelX raised $500K (Seed) on January 7, 2025.
- Arcuro Medical raised an undisclosed amount (Series A) on January 7, 2025.
- SpineGuard® raised $104K (Pre-Seed) on January 7, 2025.
- Botanic Healthcare raised $30M (Pre-Seed) on January 3, 2025.
Who to call at miDiagnostics, and when
A new round usually means miDiagnostics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day miDiagnostics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at miDiagnostics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at miDiagnostics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment miDiagnostics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
miDiagnostics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.